News

FDA recognizes need for immunogenicity assays in therapeutics with carriers or conjugates
"Nucleic Acid Therapeutics welcomes this fine addition to the armamentarium of bioanalytical assays needed to identify ...
Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension
Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering RNA (siRNA) drug ...
University of Sheffield6mon
Vaccines, therapeutics and translational nucleic acids
Our research aims to develop and utilise nucleic acid therapeutics for new and effective therapies targeting disease, but also to improve the efficiency of our manufacturing processes and analytical ...
pharmaphorum5d
Taking an ‘upside-down’ approach to mRNA delivery
A company that is working on advancing non-viral delivery technologies for nucleic acid therapeutics, such as mRNA, small interfering ribonucleic acid (siRNA), and antisense oligonucleotides (ASOs ...
Ono Commences Research Collaboration with Jorna Therapeutics to Generate Novel RNA Editing Therapeutics
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono") announced that it has entered into a research collaboration agreement with Jorna Therapeutics ...
News Medical28d
ELRIG announces Prof Rory Johnson and Dr Shalini Andersson as keynote speakers at Therapeutic Oligonucleotides 2025
Prof Rory Johnson, Associate Professor, University College Dublin, and Dr Shalini Andersson, Vice President Nucleic Acid Therapeutics, AstraZeneca will lead this year's event focused on 'drugging ...
Morningstar12d
Revive Therapeutics to Investigate Bucillamine’s Potential in Cancer Treatment
Numerous nucleic acid-based therapies are under development ... contributors to cancer initiation and growth.” About Revive Therapeutics Ltd. Revive Therapeutics is a life sciences company ...
AskBio Elects Dr. Laura Sepp-Lorenzino Independent Member of Board of Directors
AskBio Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced today that its Board of Directors has elected Independent Director Laura Sepp-Lorenzino, PhD, to the ...
Taiwan News14d
Global Nucleic Acid Isolation and Purification Market Set to Grow at a 9.23% CAGR, Reaching USD 8.47 Billion by 2030
The Global Nucleic Acid Isolation and Purification Market is segmented into drug discovery & development, precision medicine, diagnostics, agriculture and animal research, and other, based on ...
Pharmabiz6d
Exicure to initiate new clinical trial in acute myeloid leukaemia with GPC-100
Exicure to initiate new clinical trial in acute myeloid leukaemia with GPC-100: Redwood City, California Tuesday, April 15, 2025, 18:00 Hrs [IST] Exicure, Inc., an early-stage bio ...
Revive Therapeutics Ltd.: Revive Therapeutics to Investigate Bucillamine's Potential in Cancer Treatment
Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...